• γH2AX DNA Damage Detection Kit: Precision in DNA Damage Assa

  2026-04-30

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) empowers researchers to quantify DNA double-strand breaks with unparalleled sensitivity, accelerating discoveries in cancer therapy, genotoxicity, and DNA repair. Integrating robust immunofluorescence workflows and new insights from nanoparticle-enhanced radiotherapy, this kit delivers actionable, reproducible results for translational research.

• SN-38 and Camptothecin Inhibit FUBP1–FUSE Binding in Cancer

  2026-04-29

  This study uncovers a novel mechanism by which camptothecin and its analog SN-38, beyond inhibiting DNA topoisomerase I, disrupt the interaction between the oncogenic transcription factor FUBP1 and its DNA target FUSE. These results expand our understanding of how these compounds may exert anti-cancer effects, offering new avenues for advanced colon and hepatocellular carcinoma research.

• Redefining Biomolecule Detection: Cy3 TSA Fluorescence Unlea

  2026-04-29

  Explore how the Cy3 TSA Fluorescence System Kit empowers translational researchers to break through the sensitivity barriers of immunohistochemistry and in situ hybridization. Blending mechanistic insight and strategic guidance, this article highlights how tyramide signal amplification enables visualization of elusive, low-abundance targets—unlocking new frontiers in gene regulation, neurobiology, and precision pathology. Anchored by recent advances in single-cell receptor expression and epigenetic control, we chart a path for robust, reproducible, and next-generation fluorescence workflows.

• Amiloride (MK-870) in Sodium Channel Research: Applied Workf

  2026-04-28

  Amiloride (MK-870) stands out for its precision as an epithelial sodium channel and uPAR inhibitor, empowering researchers to dissect ion transport and endocytic processes with confidence. This article delivers actionable workflows, troubleshooting guidance, and protocol parameters for maximizing experimental reliability with APExBIO's Amiloride (MK-870).

• Hexa-Acylated LPS Shapes Immunotherapy Outcomes in Melanoma

  2026-04-28

  This study provides mechanistic evidence that gut microbiota-derived hexa-acylated lipopolysaccharides (LPS) enhance the efficacy of anti-PD-1 immunotherapy in melanoma. Functional metagenomics and in vivo models reveal that the structural diversity of LPS, rather than taxonomic composition alone, critically determines immune checkpoint therapy responses, offering new biomarkers and intervention strategies.

• Topotecan as a Novel Topoisomerase I Inhibitor in Oncology

  2026-04-27

  This review evaluates the unique pharmacology and clinical performance of Topotecan, a semi-synthetic camptothecin analogue designed to inhibit topoisomerase I. The study's findings establish Topotecan's role in inducing apoptosis and show its efficacy in treating small cell lung cancer and ovarian cancer, highlighting its potential in both monotherapy and combination regimens.

• HyperTrap Heparin HP Column: Precision Affinity Chromatograp

  2026-04-27

  Explore how the HyperTrap Heparin HP Column leverages HyperChrom Heparin HP Agarose for unprecedented selectivity in isolating biomolecules critical to dissecting CCR7–Notch1 stemness pathways in cancer. This deep-dive reveals advanced technical strategies and unique assay design insights for translational researchers.

• Escitalopram in Antidepressant Research: Protocols & Key Ins

  2026-04-26

  Escitalopram’s exceptional selectivity and purity empower reproducible antidepressant and anxiolytic research, especially for serotonergic signaling workflows. This guide details protocol enhancements, troubleshooting, and evidence-backed parameters, translating novel clinical insights into actionable lab strategies.

• Degarelix Acetate (SKU C8718): Reliable GnRH Receptor Antago

  2026-04-25

  This article delivers evidence-backed guidance for using Degarelix acetate (SKU C8718) in hormone secretion and proliferation assays. Drawing on recent literature and validated vendor specifications, it addresses real laboratory challenges such as assay reproducibility, protocol optimization, and data interpretation. Readers will find scenario-driven insights to optimize prostate cancer research and pituitary hormone regulation workflows.

• 3-Deazaneplanocin (DZNep): Mechanistic Leverage in Translati

  2026-04-24

  This thought-leadership article unpacks the strategic and mechanistic dimensions of 3-Deazaneplanocin (DZNep) as a dual epigenetic modulator, providing actionable insights for translational researchers. By integrating recent findings on apoptosis, cancer stem cell targeting, and the nuanced interplay with checkpoint kinase pathways, we position DZNep as a critical tool for advancing precision oncology. The discussion draws on validated literature, including current perspectives on CHK1 inhibition, and highlights APExBIO's best-in-class product offering, bridging laboratory protocol optimization with an outlook toward next-generation therapeutic strategies.

• Triptolide (PG490): Transcription Condensate Disruption in C

  2026-04-24

  Explore how Triptolide (PG490) uniquely targets transcription condensates and RNA polymerase II, offering new insights for cancer research and immunomodulation. This article highlights advanced mechanistic details and their practical impact on experimental assay design.

• O-propargyl-puromycin (OPP): Precision Protein Synthesis Det

  2026-04-23

  Explore the advanced applications of O-propargyl-puromycin (OPP) for quantifying nascent protein synthesis in cells. This article uniquely bridges mitochondrial integrity, antibody production, and practical assay design, providing new insights for proteomics and cell biology researchers.

• Protease Inhibitor Cocktail (EDTA-Free): Precision in Comple

  2026-04-23

  Discover how the Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) empowers advanced protein extraction and sensitive oncology research. Explore its critical role in protein degradation prevention and assay fidelity, with insights grounded in cutting-edge EGFR resistance studies.

• Deferasirox: Beyond Iron Chelation—Redefining Metabolic Cont

  2026-04-22

  Explore how Deferasirox, a leading oral iron chelator, is transforming our understanding of metabolic adaptation and cell death in disease models. This article uniquely connects lysosomal nutrient sensing with practical assay design, equipping researchers with actionable scientific and protocol insights.

• Energy Deficiency, ATG4B Nuclear Translocation, and DNA Repa

  2026-04-22

  This study reveals how energy deficiency triggers ATG4B nuclear translocation, which impairs PRMT1-mediated DNA repair and accelerates leukemia progression. The findings uncover a mechanistic link between cellular metabolism and genomic instability, highlighting new therapeutic possibilities for acute myeloid leukemia (AML).

16315 records 1/1088 page Next 12345 下5页 Last page